Cargando…
Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria
The autosomal dominantly inherited disease AIP (acute intermittent porphyria) is caused by mutations in HMBS [hydroxymethylbilane synthase; also known as PBG (porphobilinogen) deaminase], the third enzyme in the haem biosynthesis pathway. Enzyme-intermediates with increasing number of PBG molecules...
Autores principales: | Bustad, Helene J., Vorland, Marta, Rønneseth, Eva, Sandberg, Sverre, Martinez, Aurora, Toska, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738108/ https://www.ncbi.nlm.nih.gov/pubmed/23815679 http://dx.doi.org/10.1042/BSR20130045 |
Ejemplares similares
-
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
por: Bustad, Helene J., et al.
Publicado: (2020) -
Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function
por: Christie, Marthe S., et al.
Publicado: (2022) -
Two Novel Hydroxymethylbilane Synthase Splicing Mutations Predispose to Acute Intermittent Porphyria
por: Zhang, Yanping, et al.
Publicado: (2021) -
Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators
por: Bustad, Helene J., et al.
Publicado: (2021) -
A novel heterozygous mutation in the hydroxymethylbilane synthase gene in a case with acute intermittent porphyria
por: Ghosh, Ritwik, et al.
Publicado: (2022)